Randall G. Rupp

No open positions remaining

78 year

Health Technology

Consumer Services

Profile

Randall G.
Rupp served as Director-Cell Biology at Damon Biotech, Inc. He then worked at Regeneron Pharmaceuticals, Inc. for 17 years, where he held the position of Senior Vice President-Manufacturing Operations.
After leaving Regeneron, he worked as Vice President-Manufacturing & Development at Noveome Biotherapeutics, Inc. and as Vice President-Research & Development at BioHybrid Technologies, Inc. Rupp holds a doctorate degree from The University of Texas at Austin.

Former positions of Randall G. Rupp

Companies	Position	End
REGENERON PHARMACEUTICALS, INC.	Corporate Officer/Principal	02/04/2008
Damon Biotech, Inc. Damon Biotech, Inc. BiotechnologyHealth Technology Manufactures biological products	Corporate Officer/Principal	-
BioHybrid Technologies, Inc.	Chief Tech/Sci/R&D Officer	-
Noveome Biotherapeutics, Inc. Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines	Corporate Officer/Principal	-

See the detail of Randall G. Rupp's experience

Training of Randall G. Rupp

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Randall G. Rupp's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases	Health Technology
Damon Biotech, Inc. Damon Biotech, Inc. BiotechnologyHealth Technology Manufactures biological products	Health Technology
The University of Texas at Austin The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Noveome Biotherapeutics, Inc. Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines	Health Technology
BioHybrid Technologies, Inc.